Abiopharma

Investors presentation for Q1

Examining an asset acquisition from Saiticon by a new corporation, it intends to issue to the public shares of the new corporation, details

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis

Compass Pathways - Compass Pathways Elects Kathleen Tregoning to Board of Directors

Dollar Tree, Inc. Reports First Quarter Results

Compass Pathways Elects Kathleen Tregoning to Board of Directors

Paramount Gold Announces Results of Feasibility Study for the Grassy Mountain Gold Project

Nova Commences Fully Funded 2026 Estelle Exploration and Project Development Programs

MAYFAIR GOLD CONTINUES TO BUILD PROJECT TEAM WITH ADDITION OF DIRECTOR OF PROJECTS

Hyperscale Data Announces Termination of the Sales Agreement Providing for Its ATM Offering